[Antimicrobial susceptibility of uropathogens from uncomplicated urinary tract infection in a pediatric hospital].

Autor:	López-Martínez B; Subdirección de Servicios Auxiliares de Diagnóstico, Hospital Infantil de México Federico Gómez, México, D.F., México. Electronic address: brisalm@yahoo.com.mx., Calderón-Jaimes E; Laboratorio de Inmunoquímica y Biología Celular, Hospital Infantil de México Federico Gómez, México, D.F., México., Olivar-López V; Departamento de Urgencias, Hospital Infantil de México Federico Gómez, México, D.F., México., Parra-Ortega I; Departamento de Laboratorio Clínico, Hospital Infantil de México Federico Gómez, México, D.F., México., Alcázar-López V; Departamento de Laboratorio Clínico, Hospital Infantil de México Federico Gómez, México, D.F., México., Castellanos-Cruz MDC; Departamento de Laboratorio Clínico, Hospital Infantil de México Federico Gómez, México, D.F., México., de la Garza-López A; Departamento de Epidemiología, Hospital Infantil de México Federico Gómez, México, D.F., México.
Jazyk:	Spanish; Castilian
Zdroj:	Boletin medico del Hospital Infantil de Mexico [Bol Med Hosp Infant Mex] 2014 Nov - Dec; Vol. 71 (6), pp. 339-345. Date of Electronic Publication: 2015 May 19.
DOI:	10.1016/j.bmhimx.2015.01.001
Abstrakt:	Background: Urinary tract infection in children is well recognized as a cause of acute morbidity and chronic medical conditions. As a result, appropriate use of antimicrobial agents, however, increases antibiotic resistance and complicates its treatment due to increased patient morbidity, costs, rates of hospitalization, and use of broader-spectrum antibiotics. The goal of this study was to determine antibiotic susceptibility to commonly used agents for urinary tract infection against recent urinary isolates. Methods: A total of 457 consecutive children attending the emergency room at the Hospital Infantil de México Federico Gómez with symptoms of uncomplicated lower urinary tract infection were eligible for inclusion. Patients who had had symptoms for≥7 days and those who had had previous episodes of urinary tract infection, received antibiotics or other complicated factors were excluded. Midstream and catheter urine specimens were collected. All isolates were identified and the in vitro activities of antimicrobials were determined. Results: The most frequently isolated urinary pathogens were as follows: Escherichia coli (E. coli) (312, 68.3%), Enterococcus spp. (42, 11%), Klebsiella pneumoniae (K. pneumoniae) (40, 8.7%), Pseudomonas aeruginosa (P. aeruginosa) (34, 7.5%), Proteus mirabilis (P. mirabilis) (21, 4.5%), Enterobacter cloacae (8, 1.7%). The resistance to trimetoprim/sulfametoxazol (%) was 73.7, 62.2, 100, 52, and 50, respectively, for E. coli, K. pneumoniae, P. aeruginosa, P. mirabilis and Enterobacter spp., 92.5 for Enterococcus faecalis (E. faecalis) and 49.9 for Enterococcus faecium (E. faecium). Ampicillin was 86.3, 45, 100, 47.9, and 66.6% for the same strains, ciprofloxacin 33.8, 9, 18.8, 0, 0%, nitrofurantoin 4.4, 13, 97.7, 70, 0%; to E. faecalis 0% and 16.7% to E. faecium. Conclusions: Frequently prescribed empirical agents for uncomplicated urinary tract infection demonstrate lowered in vitro susceptibilities when tested against recent clinical isolates. (Copyright © 2014 Hospital Infantil de México Federico Gómez. Publicado por Masson Doyma México S.A. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu